8-K current report · filed Oct 23, 2026

ACADIA PHARMACEUTICALS INC (ACAD) 8-K Current Report: October 23, 2026

Item 5.02ACAD overview

Short answer

ACADIA PHARMACEUTICALS INC (ACAD) filed an 8-K current report with the SEC on October 23, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Elizabeth H.Z. Thompson retires October 23, 2026 as Executive Vice President and Head of Research and Development.

ACADIA PHARMACEUTICALS INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Elizabeth H.Z. Thompson retires October 23, 2026 as Executive Vice President and Head of Research and Development
  • Limited consulting arrangement through December 31, 2026, preserving short-term R&D transition support
  • Replacement search underway, creating leadership continuity risk for Acadia’s research and development programs
  • Departure for personal reasons, with no misconduct or disagreement disclosed

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ACADIA PHARMACEUTICALS INC 8-K filings

Get the next ACAD 8-K as it lands

Follow ACAD for push alerts, or ask the research agent what this filing means.